Anil D'Cruz, MD, on Elective Neck Dissection in Node-Negative Early Oral Cancer 
    		2015 ASCO Annual Meeting
    	
    	
    	
    
        Anil D’Cruz, MD, of Tata Memorial Hospital, discusses results from his study that seem to resolve a 50-year-long debate on performing elective neck dissection at the time of primary surgery––a potentially practice-changing finding (Abstract LBA3).
    
    
    
    
       
       
    		Claus Garbe, MD
		
		
        
		
		
		
		Claus Garbe, MD, of the University of Tuebingen, discusses the survival of sentinel lymph node biopsy–positive melanoma patients with and without complete lymph node dissection (Abstract LBA9002).
			
			
     	
    
       
       
    		Gregory T. Armstrong, MD, MSCE
		
		
        
		
		
		
		Gregory T. Armstrong, MD, MSCE, of St. Jude Children's Research Hospital, discusses the findings of a landmark survivorship study (Abstract LBA2).
			
			
     	
    
       
       
    		Charles F. von Gunten, MD, PhD
		
		
        
		
		
		
		Charles F. von Gunten, MD, PhD, of OhioHealth Kobacker House discusses the ROMANA 1 and 2 trials on cachexia in NSCLC and a study on olanzapine vs fosaprepitant for the prevention of nausea and vomiting (Abstracts 9500 and 9502).
			
			
     	
    
       
       
    		Leonard Saltz, MD
		
		
        
		
		
		
		Leonard Saltz, MD, of Memorial Sloan Kettering Cancer Center, discusses how the cost of care affects behavior and decision-making on the part of patients and oncologists.
			
			
     	
    
       
       
    		Andrew James Martin, PhD, and Anthony J. Olszanski, RPh, MD
		
		
        
		
		
		
		Andrew James Martin, PhD, of NHMRC Clinical Trials Centre, University of Sydney, and Anthony J. Olszanski, RPh, MD, of Fox Chase Cancer Center, discuss a form of vitamin B3 that reduced the incidence of new nonmelanoma skin cancers in high-risk patients (Abstract 9000).